Clinical Trial: A Prospective, Multicenter, Single-Arm Study Evaluating the Efficacy and Safety of Golidocitinib Monotherapy in Patients with Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia (China)

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Multicenter, Single-Arm Study Evaluating the Efficacy and Safety of Golidocitinib Monotherapy in Patients with Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134749

Registration Time: 2026/10/20

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital, School of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341476

Published by HT Digital Content Services with permission from Health Daily Digest....